EquityZen Growth Technology Fund LLC - Series 21
Raised
$480K
Investors
9
Min Invest
$0
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 21 is a Delaware-domiciled pooled investment fund filed by EquityZen on 2015-12-03, raising $480K from 9 investors under Rule 506(b) and Section 3(c)(1). This series is part of EquityZen's platform with 1,891 related EDGAR entities facilitating pre-IPO secondary market access.
This pre-IPO pooled fund uses the standard 506(b)/3(c)(1) exemption pattern common to private secondary market vehicles. With an average commitment of approximately $53K per investor, it reflects typical retail-accessible pre-IPO fund sizing from the mid-2010s EquityZen platform vintages.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
Equity Zen LLC
Executive Officer, Director · New York, NY
Shriram Bhashyam
Executive Officer, Director · New York, NY
Assure Fund Management II, LLC
Director · Salt Lake City, UT
Jens Beyrich
Executive Officer · Salt Lake City, UT
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
